logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Glaxosmithkline LLC


USPTO Granted Patents = 358

% Expired Patents = 52.5



Trademarks = 113

Forward Citations = 2,600

Loading Chart...
Loading Chart...

660 inventors (with patents filed for the assignee):

goldMedal Diane Mary Coe (18 out of 40 patents)

silverMedal Stephen Allan Smith (17 out of 42 patents)

bronzeMedal William Henry Miller (15 out of 73 patents)

4.  Steven David Knight (15 out of 50 patents)

5.  Mui Cheung (13 out of 43 patents)

6.  Ralph A Rivero (13 out of 14 patents)

7.  Rosanna Tedesco (12 out of 12 patents)

8.  Snigdha Mishra (12 out of 12 patents)

9.  Meagan B Rouse (12 out of 18 patents)

10.  Gustav R Fenton (12 out of 15 patents)

11.  Xinrong Tian (11 out of 15 patents)

12.  Junya Qu (10 out of 11 patents)

13.  Emmanuel Hubert Demont (10 out of 23 patents)

14.  Neil W Johnson (10 out of 20 patents)

15.  Jeffrey S Brunner (10 out of 10 patents)


Core Competencies:
Pharmaceutical Compositions
Prolyl Hydroxylase Inhibitors
Myelofibrosis Treatment
Eosinophilic Bronchitis
Sirtuin Modulators
PI3 Kinase Inhibitors
Diacylglycerol Acyltransferase Inhibitors
Bromodomain Inhibitors
Pyrazolopyrimidine Compounds
Indoles
HIV Treatment
Omega-3 Fatty Acids

358 patents:

1. 12576089 - Platelet count-agnostic methods of treating myelofibrosis (2026-03-17),
2. 12570614 - Phenyl Amino Pyrimidine Compounds and Uses Thereof (2026-03-10),
3. RE50497 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2025-07-22),
4. D1042109 - Package (2024-09-17),
5. 11963962 - Platelet count-agnostic methods of treating myelofibrosis (2024-04-23),
6. 11643397 - Prolyl hydroxylase inhibitors (2023-05-09),
7. 11390671 - Biopharmaceutical compositions and methods for pediatric patients (2022-07-19),
8. 11325972 - Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody (2022-05-10),
9. D920093 - Package (2021-05-25),
10. 10745449 - UspA2 protein constructs and uses thereof (2020-08-18),
11. 10660898 - Benzimidazole derivatives as PI3 kinase inhibitors (2020-05-26),
12. 10590135 - Substituted bridged urea analogs as sirtuin modulators (2020-03-17),
13. 10478426 - Enhancer of Zeste Homolog 2 inhibitors (2019-11-19),
14. 10392625 - Host cells and methods of use (2019-08-27),
15. 10391717 - Package and heat sealing device (2019-08-27),
GlaxoSmithKline LLC is a leading British pharmaceutical and healthcare company. With a mission to improve the quality of human life, GSK specializes in research, development, manufacturing, and marketing of pharmaceutical products, vaccines, and consumer healthcare products. GSK focuses on areas such as respiratory, HIV/AIDS, vaccines, immuno-inflammation, and oncology. Visit their website for more information and to explore their diverse portfolio of products.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Glaxosmithkline LLC
358 Patents

#21 in Wilmington, DE

#27 in Delaware

#1,271 in US

#2,560 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America

Glaxosmithkline LLC

Forward Citations = 2,600

660 inventors:

goldMedal Diane Mary Coe (18 out of 40 patents)

silverMedal Stephen Allan Smith (17 out of 42 patents)

bronzeMedal William Henry Miller (15 out of 73 patents)

4.  Steven David Knight (15 out of 50 patents)

5.  Mui Cheung (13 out of 43 patents)

Please report any incorrect information to [email protected]
Loading…